Assessment of insulin sensitivity with minimal model: Role of model assumptions

American Journal of Physiology - Endocrinology and Metabolism

Volumn 272, Issue 5 35-5, 1997, Pages

  Mari, Andrea ^a  

^a CNR   (Italy)

Author keywords

glucose effectiveness; intravenous glucose tolerance test; non insulin dependent diabetes

Indexed keywords

GLUCOSE; INSULIN;

ARTICLE; GLUCONEOGENESIS; GLUCOSE TRANSPORT; HUMAN; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031007911     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1997.272.5.e925     Document Type: Article

References (29)

1. Avogaro, A., J. D. Bristow, D. M. Bier, C. Cobelli, and G. Toffolo. Stable-label intravenous glucose tolerance test minimal model. Diabetes 38: 1048-1055, 1989.
2. Avogaro, A., P. Vicini, A. Valerio, A. Caumo, and C. Cobelli. The hot but not the cold minimal model allows precise assessment of insulin sensitivity in NIDDM subjects. Am. J. Physiol. 270 (Endocrinol. Metab. 33): E532-E540, 1996.
3. Beard, J. C., R. N. Bergman, W. K. Ward, and D. Porte, Jr. The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes 35: 362-369, 1986.
4. Bergman, R. N. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38: 1512-1527, 1989.
5. Bergman, R. N., Y. Z. Ider, C. R. Bowden, and C. Cobelli. Quantitative estimation of insulin sensitivity. Am. J. Physiol. 236 (Endocrinol. Metab. Gastrointest. Physiol. 5): E667-E677, 1979.
6. Bergman, R. N., R. Prager, A. Vølund, and J. M. Olefsky. Equivalence of the insulin sensitivity index in man derived by the minimal model method and the euglycemic glucose clamp. J. Clin. Invest. 79: 790-800, 1987.
7. Best, J. D., G. J. Taborsky, Jr., J. B. Halter, and D. Porte, Jr. Glucose disposal is not proportional to plasma glucose level in man. Diabetes 30: 847-850, 1981.
8. Caumo, A., and C. Cobelli. Hepatic glucose production during the labeled IVGTT: estimation by deconvolution with a new minimal model. Am. J. Physiol. 264 (Endocrinol. Metab. 27): E829-E841, 1993.
9. Caumo, A., A. Giacca, M. Morgese, G. Pozza, G. Micossi, and C. Cobelli. Minimal models of glucose disappearance: lessons from the labelled IVGTT. Diabetic Med. 8: 822-832, 1991.
10. Coates, P. A., S. D. Luzio, P. Brunel, and D. R. Owens. Comparison of estimates of insulin sensitivity from minimal model analysis of the insulin-modified frequently sampled intravenous glucose tolerance test and the isoglycemic hyperinsulinemic clamp in subjects with NIDDM. Diabetes 44: 631-635, 1995.
11. Coates, P. A., R. L. Ollerton, S. D. Luzio, I. S. Ismail, and D. R. Owens. Reduced sampling protocols in estimation of insulin sensitivity and glucose effectiveness using the minimal model. Diabetes 42: 1635-1641, 1993.
12. Cobelli, C., G. Pacini, G. Toffolo, and L. Saccà. Estimation of insulin sensitivity and glucose clearance from minimal model: new insights from labeled IVGTT. Am. J. Physiol. 250 (Endocrinol. Metab. 13): E591-E598, 1986.
13. Cobelli, C., G. Toffolo, and E. Ferrannini. A model of glucose kinetics and their control by insulin, compartmental and noncompartmental approaches. Math. Biosci. 72: 291-315, 1984.
14. DeFronzo, R. A., and E. Ferrannini. Influence of plasma glucose and insulin concentration on plasma glucose clearance in man. Diabetes 31: 683-688, 1982.
15. Ferrannini, E., J. D. Smith, C. Cobelli, G. Toffolo, A. Pilo, and R. A. DeFronzo. Effect of insulin on the distribution and disposition of glucose in man. J. Clin. Invest. 76: 357-364, 1985.
16. Finegood, D. T., I. M. Hramiak, and J. Dupre. A modified protocol for estimation of insulin sensitivity with the minimal model of glucose kinetics in patients with insulin-dependent diabetes. J. Clin. Endocrinol. Metab. 70: 1538-1549, 1990.
17. Finegood, D. T., G. Pacini, and R. N. Bergman. The insulin sensitivity index. Correlation in dogs between values determined from the intravenous glucose tolerance test and the euglycemic glucose clamp. Diabetes 33: 362-368, 1984.
18. Henriksen, J. E., F. Alford, A. Handberg, A. Vaag, G. M. Ward, A. Kalfas, and H. Beck-Nielsen. Increased glucose effectiveness in normoglycemic but insulin-resistant relatives of patients with non-insulin-dependent diabetes mellitus. A novel compensatory mechanism. J. Clin. Invest. 94: 1196-1204, 1994.
19. Kahn, S. E., L. J. Haff, M. W. Schwartz, J. C. Beard, R. N. Bergman, G. J. Taborsky, Jr., and D. Porte, Jr. Treatment with a somatostatin analog decreases pancreatic B-cell and whole body sensitivity to glucose. J. Clin. Endocrinol. Metab. 71: 994-1002, 1990.
20. Kahn, S. E., R. L. Prigeon, D. K. McCulloch, E. J. Boyko, R. N. Bergman, M. W. Schwartz, J. L. Neifing, W. K. Ward, J. C. Beard, J. P. Palmer, and D. Porte, Jr. The contribution of insulin-dependent and insulin-independent glucose uptake to intravenous glucose tolerance in healthy human subjects. Diabetes 43: 587-592, 1994.
21. Martin, B. C., J. H. Warram, A. S. Krolewski, R. N. Bergman, J. S. Soeldner, and C. R. Kahn. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340: 925-929, 1992.
22. Prigeon, R. L., M. E. Røder, D. Porte, Jr., and S. E. Kahn. The effect of insulin dose on the measurement of insulin sensitiv-ity by the minimal model technique. J. Clin. Invest. 97: 501-507, 1996.
23. Quon, M. J., C. Cochran, S. I. Taylor, and R. C. Eastman. Non-insulin-mediated glucose disappearance in subjects with IDDM. Discordance between experimental results and minimal model analysis. Diabetes 43: 890-896, 1994.
24. Saad, M. F., R. L. Anderson, A. Laws, R. M. Watanabe, W. W. Kades, Y.-D. Ida Chen, R. E. Sands, D. Pei, P. J. Savage, and R. N. Bergman. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes 43: 1114-1121, 1994.
25. Taniguchi, A., Y. Nakai, K. Doi, M. Fukushima, I. Nagata, H. Kawamura, H. Imura, M. Suzuki, and K. Tokuyama. Glucose effectiveness in two subtypes within impaired glucose tolerance. A minimal model analysis. Diabetes 43: 1211-1217, 1994.
26. Taniguchi, A., Y. Nakai, M. Fukushima, H. Kawamura, H. Imura, I. Nagata, and K. Tokuyama. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes 41: 1540-1546, 1992.
27. Verdonk, C. A., R. A. Rizza, and J. E. Gerich. Effects of plasma glucose concentration on glucose utilization and glucose clearance in normal man. Diabetes 30: 535-537, 1981.
28. Welch, S., S. S. P. Gebhart, R. N. Bergman, and L. S. Phillips. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71: 1508-1518, 1990.
29. Yang, Y. J., J. H. Youn, and R. N. Bergman. Modified protocols improve insulin sensitivity estimation using the minimal model. Am. J. Physiol. 253 (Endocrinol. Metab. 16): E595-E602, 1987.